Abstract Chitinase‐3‐like protein 1 (CHI3L1) is a secreted glycoprotein characterized by its
ability to regulate multiple biological processes, such as the inflammatory response and …

The advent of highly effective disease modifying therapy has transformed the landscape of
multiple sclerosis (MS) care over the last two decades. However, there remains a critical …

Several biomarkers from multiple sclerosis (MS) patients' biological fluids have been
considered to support diagnosis, predict disease course, and evaluate treatment response …

Several reports have pointed out that Chitinases are expressed and secreted by various cell
types of central nervous system (CNS), including activated microglia and astrocytes. These …

Introduction Multiple sclerosis (MS) is the most frequent demyelinating disease of the central
nervous system. Although there is currently there is no definite cure for MS, new therapies …

Aim: To investigate whether the estimation of cerebrospinal fluid (CSF) and brain YKL-40
levels may be used as an efficient biomarker for Parkinson's disease (PD). Methods …

Elevated levels of Chitinase-3-like protein-1 (CHI3L1) in cerebrospinal fluid have previously
been linked to inflammatory activity and disease progression in multiple sclerosis (MS) …

Drawing on social exchange theory and reasoned action theory, this study aims to
investigate the relationships among residents' perceptions, community participation …

The progressive forms of multiple sclerosis (MS) primary progressive MS (PPMS) and
secondary progressive MS (SPMS) are clinically distinguished by the rate at which …

Multiple sclerosis is a recurrent and progressive inflammatory autoimmune disease causing
demyelination in the central nervous system. Nowadays, the number of MS patients is …